» Articles » PMID: 35995130

Strategies to Improve the Recruitment and Retention of Underserved Children and Families in Clinical Trials: A Case Example of a School-supervised Asthma Therapy Pilot

Abstract

Background: Due to underrepresentation of racial/ethnic minority and low-income groups in clinical studies, there is a call to improve the recruitment and retention of these populations in research. Pilot studies can test recruitment and retention practices for better inclusion of medically underserved children and families in subsequent clinical trials. We examined this using a school-based asthma intervention, in preparation for a larger clinical trial in which our goal is to include an underserved study population.

Methods: We recruited children with poorly controlled asthma in a two-site pilot cluster randomized controlled trial of school-supervised asthma therapy versus enhanced usual care (receipt of an educational asthma workbook). We sought a study population with a high percentage of children and families from racial/ethnic minority and low-income groups. The primary outcome of the pilot trial was recruitment/retention over 12 months. Strategies used to facilitate recruitment/retention of this study population included engaging pre-trial multi-level stakeholders, selecting trial sites with high percentages of underserved children and families, training diverse medical providers to recruit participants, conducting remote trial assessments, and providing multi-lingual study materials.

Results: Twenty-six children [42.3% female, 11.5% Black, 30.8% Multiracial (Black & other), 76.9% Hispanic, and 92.3% with family income below $40,000] and their caregivers were enrolled in the study, which represents 55.3% of those initially referred by their provider, with 96.2%, 92.3%, and 96.2% retention at 3-, 6-, and 12-month follow-up, respectively.

Conclusion: Targeted strategies facilitated the inclusion of a medically underserved population of children and families in our pilot study, prior to expanding to a larger trial.

Citing Articles

Promoting Diversity through an Understanding of Barriers and Drivers for Inclusive Clinical Trials.

de Bruin A, Masullo J, Sine S, Getz K Ther Innov Regul Sci. 2025; .

PMID: 40009138 DOI: 10.1007/s43441-025-00751-9.


Retention and the Intersection of Structural Inequities in a Breastfeeding Intervention Study.

LaPlant H, Francis-Edoziuno C, Guan Z, Aderibigbe T, Chang X, Alhabodal A medRxiv. 2024; .

PMID: 38559187 PMC: 10980120. DOI: 10.1101/2024.03.15.24304355.


Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science.

Byams V, Baker J, Bailey C, Connell N, Creary M, Curtis R Expert Rev Hematol. 2023; 16(sup1):87-106.

PMID: 36920863 PMC: 11075128. DOI: 10.1080/17474086.2023.2183836.

References
1.
Trivedi M, Patel J, Hoque S, Mizrahi R, Biebel K, Phipatanakul W . Alignment of stakeholder agendas to facilitate the adoption of school-supervised asthma therapy. Pediatr Pulmonol. 2019; 55(3):580-590. PMC: 7018546. DOI: 10.1002/ppul.24611. View

2.
Kagawa-Singer M . Improving the validity and generalizability of studies with underserved U.S. populations expanding the research paradigm. Ann Epidemiol. 2001; 10(8 Suppl):S92-103. DOI: 10.1016/s1047-2797(00)00192-7. View

3.
Coakley M, Fadiran E, Parrish L, Griffith R, Weiss E, Carter C . Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials. J Womens Health (Larchmt). 2012; 21(7):713-6. PMC: 3432572. DOI: 10.1089/jwh.2012.3733. View

4.
Trivedi M, Patel J, Lessard D, Kremer T, Byatt N, Phipatanakul W . School nurse asthma program reduces healthcare utilization in children with persistent asthma. J Asthma. 2017; 55(10):1131-1137. PMC: 5988937. DOI: 10.1080/02770903.2017.1396473. View

5.
Niranjan S, Wenzel J, Martin M, Fouad M, Vickers S, Konety B . Perceived Institutional Barriers Among Clinical and Research Professionals: Minority Participation in Oncology Clinical Trials. JCO Oncol Pract. 2021; 17(5):e666-e675. PMC: 8257918. DOI: 10.1200/OP.20.00970. View